SynthesisJAMA network open2025

PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis.

Stamatios Petousis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.